胰腺和门静脉联合切除人造血管替代治疗胰头癌二例报告  

Combined resection of the pancreas and portal vein replaced by blood vessel prosthesis for pancreatic head carcinoma:report of two cases

作　　者：陈福真[1] 符伟国[1] 徐欣[1] 杨珏[1] 肖占祥 陈斌[1] 

机构地区：[1]上海医科大学中山医院血管外科

出　　处：《中华外科杂志》1997年第3期147-149,共3页Chinese Journal of Surgery

摘　　要：为了提高胰头癌切除率和患者的存活率，作者采用胰腺和门静脉联合切除术治疗２例胰头癌浸润门静脉的患者。门静脉采用直径８ｍｍＧｏｒｅ－Ｔｅｘ人造血管重建。随访结果：１例存活３２个月且无肿瘤复发，Ｂ超和ＣＴ检查显示移植物通畅。另１例存活２０个月移植物血流通畅。作者认为胰头癌累及门静脉而无转移时，胰腺和门静脉联合切除人造血管替代是值得的。自体颈内静脉和Ｇｏｒｅ－Ｔｅｘ是重建门静脉合适材料。The resectability and prognosis of carcinoma of the pancreatic head are still poor.The higher resectability rate was achieved by combined resection of the pancreas and portal vein.Two patients in whom the portal vein,surrounded but not penetrated by pancreatic carcinoma,was resected and replaced by an expanded Teflon (Gore Tex) tube (diameter 8mm).One patient,who survived 32 months without recurrence of disease,had a ultrasonography and CT proved patent graft 6 and 32 months after operation.A second survivor had a patent graft at 20 month.Excision of involved portal vein during pancreatoduodenectomy for carcinoma of the head of the pancreas is a feasible and valid procedure in the absence of metastases.Vein grafting is the best means for portal vein reconstruction.Gore Tex appears to be suitable prosthesis when the portal vein must be sacrificed.

关 键 词：胰腺肿瘤 人工血管 外科手术 胰腺 门静脉 

分 类 号：R735.905[医药卫生—肿瘤]